Clinical trial
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
NCT01681290
Study timeline
Study start (unknown)2012-10-01Date precision: month
Registry last updated2015-01-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetic Peripheral Neuropathyunresolved
Interventions
CBX129801DRUG
Sponsors & collaborators
Cebix Incorporatedlead sponsor
Mapped research locations
HoustonTexas, United States2New YorkNew York, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1DallasTexas, United States1AtlantaGeorgia, United States1TorontoOntario, Canada1San AntonioTexas, United States1San FranciscoCalifornia, United States1San DiegoCalifornia, United States1OmahaNebraska, United States1Ann ArborMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01681290 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.